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Galactose-al,3-galactose (aGal) epitopes, the synthe-
sis of which requires the enzyme product of al,3-galac-
tosyltransferase (al,3GT), are sugar chains on the cell 
surface of most mammalian species. Notable exceptions 
are higher primates including Old World monkeys, apes, 
and humans. The aGal-negative species as well as mice 
with deletion of the al,3GT gene produce abundant anti-
aGal antibodies. The evolutionary loss of aGal epitopes 
has been attributed to point mutations in the coding 
region of the gene. Because no transcripts could be 
found in the higher primate species with Northern blot 
analysis, a potential alternative explanation has been 
loss of upstream regulation of the gene. Here, we have 
demonstrated that the rhesus promoter is functional. 
More importantly, a variety of full· length transcripts 
were detected with sensitive peR·based methods in the 
tissues of rhesus monkeys, orangutans, and humans. 
Five crucial mutations were delineated in the coding 
region of the human and rhesus and three in the orang-
utan, anyone of which could be responsible for inacti-
vation of the al,3GT gene. Two of the mutations were 
shared by all three higher primates. These findings, 
which elucidate the molecular basis for the evolutionary 
loss of aGal expression, may have implications in medi-
cal research. 
Most mammals express the cell surface carbohydrate epitope 
galactose-a1,3-galactose (aGall,l with notable exceptions that 
include Old World monkeys, apes, and humans (1). With the 
loss of the aGal epitopes, the synthesis of which is dependent 
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on enzyme product of the a1,3-galactosyltransferase (a1,3GT) 
gene, higher primates produce anti-aGal antibodies (2) that are 
responsible for the hyperacute rejection of organs transplanted 
from aGal-positive donors (3). 
In 1989, Joziasse et al. (4) reported the sequence of full-
length cDNA clone of the bovine a1,3GT gene and demon-
strated the presence of this gene in the DNA of human cell 
lines. Using an 804-bp fragment derived from bovine full-
length cDNA as a probe, they also detected mRNA transcripts 
in bovine and marmoset (New World monkey) but not in hu-
man or Mrican green monkey cell lines (4). The absence of 
a1,3GT mRNA has since been widely viewed as a feature of all 
Old World monkeys, apes, and humans (5, 6). The molecular 
basis for the inactivation of the a1,3GT gene in the aGal-
negative species has been attributed to a mutation(s) localized 
to a partial sequence of exon 9 (4, 5, 7). 
Stimulated by the current interest in producing transgenic 
pigs for clinical use as tissue and organ xenograft donors, the 
cDNA for the a1,3GT gene of the aGal-positive pig was isolated 
(8), and the coding regions were characterized (9-12). Further, 
the full genomic organization of the porcine a1,3GT, gene in-
cluding its upstream regulatory region, was completed (12). A 
CpG island (i.e. a C connected by a 3'-5' phosphodiester bond 
to a G) characteristic of housekeeping genes was observed 
around exon 1 ofthe pig a1,3GT gene (12). It is of interest that 
a CpG island was not present in the mouse gene (13-15), 
suggesting that the upstream regulatory regions might be spe-
cies-specific even though the enzyme function of the a1,3GT 
gene product was identical (15). If so, it would be conceivable 
that the loss of aGal expression in higher primates could be due 
to mutation in the upstream regulatory region (16). 
As a further step in a phylogenetic comparison of the aGal-
positive pig with the higher primates, we employed a PCR-
based cloning strategy to avoid the potential artifacts of extrap-
olating from partial sequences and cross-species hybridization. 
After obtaining the full coding region of the aGal-positive mar-
moset and cebus a1,3GT gene, we identified the full coding 
region of the gene in the aGal-negative rhesus monkey, orang-
utan, and human, as well as the genomic organization and 
upstream regulatory region in the rhesus and human. In all 
three aGal-negative primate species, we found that the a1,3GT 
gene produces a variety of transcripts that were confirmed in 
the rhesus samples with Northern blot analysis. The tran-
scripts contained crucial mutations in addition to the one(s) 
described previously in exon 9 of the rhesus (6), orangutan (6), 
and human (5, 6). Taken together, our findings suggest sub-
stantial revisions of the characterization of the a1,3GT gene 
10114 This paper is available on line at http://www.jbc.org 
Primate al,3-Galactosyltransferase Gene 10115 
TABLE I 
Sequences of oligonucleotides used as PCR primers 
GenBank™ accession numbers are: human, J05421; orangutan, 
M73305; rhesus, M73306. 
Human 
H9a: 5' -CTGAATGGGTGTTCCTCCAGAAATGGCT-3' 
H9b: 5' -TGGAAGACCTGGTCCACATCCATGCAG-3' 
H9m: 5' -GAAGAGGTGGCAAGACATCAGCATGATGC-3' 
H9n: 5' -CTGCATGGATGTGGACCAGGTCTTCCA-3' 
Orangutan 
U9a: 5'-TAGGCCAGTCGGTGGCTCAGCTACAGG-3' 
U9b: 5'-TGGCGGTACAAGGCAGATCCCGATGAC-3' 
U9m: 5'-GTGATGTTGAGAACCTGAATGGGTGTTG-3' 
U9n: 5' -CTGGCCAAATGGAATATATGCTGCTGACTC-3' 
Rhesus 
R9a: 5' -GAGGTCAAGCCAGAGAAGAGGTGGCAACA-3' 
R9b: 5' -GACTTCCTCTTCTGCATGGATGTAGACCAG-3' 
R9m: 5' -ATGTTGAGAACCTGAATGGGTGTTCCTCC-3' 
R9n: 5' -CTGGCCAAATGGAATGCATGCTGCTGACTC-3' 
that have implications for the molecular study of primate evo-
lution and for the planning of xenotransplantation initiatives. 
EXPERIMENTAL PROCEDURES 
Genomic Organization of Human, Orangutan, and Rhesus Monkey 
CJ.l,3GT Genes-After high molecular genomic DNA was isolated from 
the PBMC of multiple healthy adult male humans, two rhesus mon-
keys, and an orangutan, libraries for the three species were constructed 
using the Universal GenomeWalkerTM Library Kit (CLONTECH, Palo 
Alto, CAl. The initial gene-specific and nested primer pairs were de-
signed from the partial exon 9 sequences of the a1,3GT gene available 
in the GenBank™ (Table I). Gene-specific and nested primer pairs for 
other regions were designed from the exonic sequences obtained from 
RACE or RT-PCR experiments (not shown). 
5'- or 3'-RACE Analyses-Using TrizoFM reagent (Invitrogen) ac-
cording to thc manufacturer's instructions, total RNA was extracted 
from rhesus PBMC and spleen samples, from human PBMC and pla-
centa (provided in the CLONTECH Marathon ™ amplification kit), and 
from orangutan PBMC. After treatment with DNase I (Ambion Inc., 
Austin, TX), poly(A)+ RNA was separated from total RNA using the 
Dynabeads™ mRNA purification Kit (Dynal, Oslo, Norway) in accord-
ance with the protocol provided. Using the primers listed in Table I, the 
5'- and 3'-RACE procedures were performed with the Marathon™ 
cDNA amplification kit. The thermal cycling conditions on a 
PerkinElmer GeneAmp System 9600 or 9700 thermo cycler and TaKaRa 
LA Taq (Takara Shuzo, Shiga, Japan) enzyme were used for PCR 
procedures. 
RT-PCR-Using total RNA derived from two rhesus monkeys, first-
strand cDNA templates for RT-PCR were generated with the Super-
Script Preamplification'l'M system (Invitrogen) according to the manu-
facturer's protocol. Based on the sequences obtained from the RACE 
experiments, primers were designed and RT-PCR was performed. Com-
parable experiments were performed with the orangutan and human-
derived specimens. The primers are listed in Table 1. 
Subcloning and Sequencing of Amplified Products-PCR products 
amplified in 5'- or 3'-RACE, GenomeWalker™-PCR, and RT-PCR were 
subcloned into the pCR II vector provided with the Original TA Clon-
ing™ Kit (Invitrogen, Carlsbad, CAl. Automated fluorescent sequenc-
ing of cloned inserts was performed using an ABI 377 Automated DNA 
Sequence Analyzer (Applied Biosystems, Inc., Foster City, CAl. 
Northern Blot Analysis-To confirm the results of RT-PCR in the 
rhesus species with NorthernMax™-GlyNorthernTM blots system 
(Ambion), total RNA was extracted from rhesus spleen tissue using 
TrizorrM as described above. Using the protocol provided with the kit, 
~ 10 JLg of total RNA from each species was blotted to the BrightStar-
Plus ™ membrane. The BrightStar™ Psoralen-biotin nonisotopic label-
ing kit was employed for the biotinylated DNA probe (a 744-bp frag-
ment of the rhesus CJ.1,3GT exon 9). 
Luciferase Assay for Promoter Activity-The Dual Luciferase™ re-
porter assay (Promega, Madison, WI) was used to evaluate the pro-
moter activity. For this purpose, a fragment of 1431 bp of the 5'-
flanking region of rhesus exon 1 was inserted into the multicloning site 
of the pGL3-Basic vector (termed pGL3-RA), which was co-transfected 
with pRL-TK vector for normalization of transfection efficiency into pig 
aortic endothelial cells using LipofectAMINE (Invitrogen). Relative lu-
ciferase activity of the pGL3-RA was measured by luminometer and 
compared with that of the pig promoter (12). 
RESULTS 
Genomic Organization of the Rhesus and Human al,3GT 
Gene-The full-length genomic organization determined by the 
combined results of GenomeWalker-PCR, RACE, and RT-PCR 
consisted of nine exons and eight introns (Fig. 1), correspond-
ing to the previously delineated porcine and mouse genomic 
structure (8-14). However, some cryptic exons or aberrant 
splicing sites were observed as described below. The total rhe-
sus and human gene size is calculated to be more than 50 kb. 
5'-RACE, 3 '-RACE, and Northern Blot Analysis of the 
al,3GT Gene-5'- and 3'-RACE experiments revealed se-
quences of the aGal-negative species that were highly homol-
ogous with the al,3GT gene of aGal-positive species. 3' -RACE 
demonstrated the presence of poly(A) (adenylation) signal and 
poiy(A) tail. Based on these sequences, we performed RT-PCR 
using a pair of primers that spanned several exons. Multiple 
bands were seen in human (Fig. 2A, a) and rhesus (Fig. 2A, c), 
whereas only one major band was seen in the orangutan (Fig. 
2A, b). The results of any exon of a given species were identical 
with all three PCR methods (i.e. RACE, RT-PCR, and GW-
PCR) (Fig. 2A). Moreover, the presence of transcripts for the 
rhesus al,3GT gene was confirmed with Northern blot hybrid-
ization (Fig. 2A, d). We concluded that the sequences identified 
with all of the detection methods were derived from authentic 
al,3GT mRNA in the respective aGal-negative species. 
Cryptic Exons-Cryptic exons were found in both the rhesus 
and human CJ.l,3GT gene, e.g. between exons 2 and 4, desig-
nated 3H in human and 3R in rhesus (Fig. 2B, a and c). Exons 
3H and 3R showed no homology with each other, and neither 
exon had any homology with the previously described mouse 
exon 3 (13). A cryptic human exon with two size variants, both 
of which had poly(A) tails, was found in 18 of 22 humans 
between exons 7 and 8 (Fig. 2B, a) and was designated 7H. At 
the end ofthe 7Ha variant, a donor splicing site was found that 
spliced to exon 9 (Fig. 2B, a). In rhesus, cryptic exons desig-
nated 6Ra and 6Rb were found between exons 6 and 7, and in 
addition, a third variant was found (6Rc) that included a re-
tained intron (Fig. 2B, c). 
Aberrant Splicing Sites-In the 5' -untranslated region, rhe-
sus exon 2 is 112 bp, whereas human exon 2 is 269 bp (Fig. 3). 
Comparative analysis revealed that the first half (110 bp, 
termed 2A) of the human exon 2 is highly homologous to rhesus 
exon 2, and the last half (159 bp, termed 2B) is similar to the 
rhesus intron 2 that extends from exon 2. Although the first 
half (138 bp, termed 8Ra) of the rhesus exon 8 (327 bpJ showed 
high homology with the porcine exon 8 (138 bp), the remaining 
half (189 bp, termed 8Rb) resembled the porcine intron 8 se-
quences extending from exon 8 (Figs. 2B, c, and 3). A single 
nucleotide deletion of G was found only in rhesus at the border 
between the region 8Ra and 8Rb (Fig. 3, position [d)), resulting 
in utilization of another downstream splicing site. 
Alternative mRNA Splicing of the Human and Rhesus 
al,3GT Gene-A variety of alternative splicing patterns were 
demonstrated in the RACE and RT-PCR experiments (Fig. 2, A 
and B). In the coding region, the predominant pattern in hu-
man consisted of exons 4 through 9. Because of the cryptic 
exons and aberrant splicing sites in the human and rhesus 
genes, the alternative splicing patterns were far more varied in 
these aGal-negative species than in aGal-positive murine or 
porcine species (8-13). 
Exon-Intron Splice Junctions of Human, Orangutan, and 
Rhesus al,3GT Gene-A comparative sequence analysis of 
splice junctions was performed on rhesus, orangutan, and hu-
man genomic DNA (Fig. 3). The results were further compared 
with the porcine species sequence (GenBank™ accession num-
bers AF22151O-AF221517) (not shown), revealing high homol-
10116 Primate al,3-Galactosyltransferase Gene 
CpG island 
GWPCR 
Long PCR 
f 
kb > -30 
> ~( __ -7 
-12 
Human 
Rhesus 
i 
-6 o 
i 
6 
> 
( 
f 
12 
6Ra 6Rb 
i 
18 
> 
8Ra 8Rb - (stop) 
24 
(> -->~ 
f 
30 
FIG.!. Genomic organization on a kb scale of the al,3GT gene of the human (above Iwrizontalline) and rhesus (below horizontal 
line). The numbered boxes indicate the approximate location of exons within the locus of the two species but do not accurately reflect the length 
of each exon. The translation start and stop codons are located in exons 4 and 9. The horizontal thick bar above exon 9 denotes the GenBank ™ data 
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FIG. 2. A, electrophoresis ofPCR(a-c) and Northern blot hybridization (d). Lane 1, electrophoresis results ofRT-PCR in the human, orangutan, 
and rhesus cDNA libraries, respectively, using a pair of primers spanning the coding region. Lane M, DNA size marker ladder (Invitrogen, l-kb 
DNA size ladder). d, Northern blot of total RNA from bovine (lane 1) or rhesus spleen tissue (lane 2) hybridized with a probe derived from rhesus 
exon 9 fragment. As expected, with in-species versus cross-species hybridization, gene expression was lower in the bovine than in the monkey 
spleen cells. B, schematic splicing variations and cryptic exons of human (a), orangutan (b), and rhesus (e ) a1,3GT gene. The closed boxes denote 
exons in the respective species. The open boxes with arrows denote cryptic exons that were not observed in the aGal-positive species. Exon 6Rc in 
rhesus has exon 6, intron 6, and exon 7 (a retained intron). 
ogy among the three species. As shown in Fig. 3, the pyrimidine 
richness in the intron 7-exon 8 boundary of both the rhesus 
and human was less than the pyrimidine content of the intron 
3-exon 4 boundary, explaining the frequency of splicing of exon 
8 in the 2 species. 
Regulatory Region and 5' -Untransplated Region of the Rhe-
sus al,3GT Gene-GenomeWalker-PCR starting at exon 1 re-
vealed that the rhesus and human upstream regulatory region 
contains several SPl/GC-box, AP2, and other consensus motifs 
in the absence of a TATA- or CAAT-box. The findings were 
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exon 1 Hu 
Rh 
---GGGCGCGGTCCTGCTCAGCCCAGCTCACCGCGCGCCGGCCCTCGGCGCCCTGGTTCTGCGGATCAG gtgggt---
---CGccGCCGGGGGGCCGGGAGCCGAGGTGTGGGCCATCCCCGAGCGCACCCAGCTTCTGCCGATCAG gtgggt---
Hu (269) ---gtctactccccatctcctgaaacagctgtttattctttcgacag GAGTTGAAACC--GGCAGGAG GTATGT 
exon 2 ---GGCTCAGGGACTTCACT gtaagt---Ou 
Rh 
[2A: 110] 
(115) 
(112) 
---gtctactccccatctcctgaaacagctgtttattcttttgacag GATTTGAAACC--ACGATGAG gtacgt---
---qtctactccctatctqctgaqqcaqctqtttattcttttgacag GAGTTGAAACC--ACGATAAG gtatgt---
exon 4 
Hu 
Ou 
Rh 
(89) ---atttaatctgttctctttttttctcccctcttcttttttcctag GAGAAAATAATG-- AAC AG gtaatt---
(89) ---gatttaatctqtccttttttttctcccctcttcttttttcctaq GAGAAAATAATG-- AAC AG gtaatt---
(89) ---atttaatctgttctcttttttttctccctcttcttttttcctag GAGAAAATAATG-- AAC AG gtaatt---
exon 5 
Hu 
Ou 
Rh 
(36) ---attaaaagtaacatgatatqtttttatttcttttttqcttttaq C ACA GAA--CAC TCA AA gtaagt---
(36) ---attaaaaqtaacatgatatgtttttatttcttttttqcttttaq C CCA GAA--CAC TCA AA gtaaqt---
(36) ---attaaaaqtaacatqatatqtttttgtttctctttcacttttag C CCA GAA--CGC TCA AA qtaagt---
exon 6 
Hu (66) ---caccacattttctaaaaatatttgtaaactttttcatttcttag A AAC CCA--AAC AAT GG gtaagg---
Ou (66) ---acaccacatttctaaaaatatttqtaacctttttcatttcttaq A AAC CCA--AAC AAT GG qtaagq---
Rh (66) ---caccacattttctaaaaacatttqtaatqtttttcatttcttaq A AAC CCA--AAC AAT GG gtaaqq---
exon 7 
Hu (116) ---tcaccttccctqccttacctqgtttactttccctttgtacttag G ATC CAC---ATC CAA A gtaaqa---
Ou (116) ---tcaccttccctgccttacctqqtttactttccctttqtacttaq G ATC CAC---ATC CAA A qtaaqa---
Rh (115) ---tcaccttccctgccttacctggtttactttccctttgtacttag G ATC CAC---ATC CAA A gtaaga---
exon 7H Hu (803) ---tttaattcaacataaatttttaaggqtqctgttttttcttccag C TTG AAG--GGATGACCTG gtatag---
[7Ha:189] 
exon 8 
Hu (138) ---ggcaaagctgccctgactcaqggaactctacgttttatcaccag 
Ou (138) ---ggcaaagctgccctgactcagqgaactctacgttttatcaccag 
Rh (327) ---tggcaaagctqccctgactcagggaactctacqtttatcaccag 
9 AAA CGC--GTC GGA AG gtaqgt---
q AAA CGC--ATT GGA AG gtaggt---
G AAA CAC--ATT GGA AG -TGGGT 
[8A: 138] ---GAACAAAATAAGAGTA~taagt---
[d] Deletion of G 
exon 9 
Hu (692) ---qgaatcccagaggataaatgttttqcttttcttctttqtttcag A TAT AAT-AAT GTC TGA-- + poly A signal 
Ou (693) ---gqaatcccagaqgataaatgttttgcttttcttctttgtttcag A TAT AAT-AAC GTC TGA-- + poly A signal 
Rh (694) ---qqaatcccaaaggttaaatgttttgcttttcttctttgtttcag A TAT ATT-ATC ATC TGA-- + poly A signal 
FIG. 3. Comparison of exon-intron boundaries of the human (H), orangutan (Ou), and rhesus (R) al,3GT gene. Capital or lowercase 
letters indicate the nucleotides of the exon or intron in each species, respectively. The numbers in parentheses indicate exon size in bp. The start 
codon in exon 4 and the authentic stop codon in exon 9 are underlined. 
similar to those in the pig gene (12). In both the rhesus and 
human, as well as the pig, the region comprises a CpG island. 
In the upstream region between -340 and -470, the high 
degree of homology between the rhesus and pig, but not be-
tween the human and pig, gene is noteworthy (Fig. 4). The 
transcription initiation site has been identified in the pig (12). 
When the transcription initiation site is identified in the hu-
man and rhesus gene, the question may be clarified as to 
whether there are differences in gene regulation between the 
human and rhesus. 
Rhesus al,3GT Gene Promoter Activity-The intensity of 
expression promoted expressed by the pGL3-RA construct was 
18-fold greater than the pGL3-Basic control, and that of pig 
was 81-fold higher (Fig. 5). 
3'-Untranslated Region of the Rhesus al,3GT Gene-The 
nucleotide divergence of the rhesus exon 9 sequence from that 
of the orangutan and human was found starting 1273 bp down-
stream from the 5' -end of exon 9 and spanning 420 bp (data not 
shown). A GenBank ™ BLAST search revealed that this diver-
gence had a striking homology with a retrovirus long terminal 
repeat sequence present in the baboon (GenBank™ accession 
number NC-000863; Ref. 17). 
Homology in the Coding Region-We compared our results of 
the human, orangutan, and rhesus sequences to our aGal-
positive marmoset and cebus New World monkey sequences 
(deposited in the GenBank™). Our marmoset sequence also 
was compared with an independently submitted sequence (18). 
Although the overall sequence from the start codon in exon 4 to 
the stop codon in exon 9 in marmoset is 1131 bp, the corre-
sponding sequence of the human (from exon 4 to exon 9 through 
exon 8) or rhesus (from exon 4 to exon 9 through exon 8Ra) was 
1128 or 1129 bp, respectively. Homology between human, 
orangutan, or rhesus to marmoset is 94.3, 94.7, or 92.4%, 
respectively. 
Comparison of Predicted Amino Acid Sequences-There were 
no frameshift mutations in the rhesus, orangutan, or human 
exons 4-6. However, five crucial mutations that might account 
for loss ofthe al,3GT expression were identified in the human 
and rhesus, and three were detected in the orangutan. It is 
noteworthy that the mutations at the position [b) and [j) were 
shared by all three species. 
In the rhesus, at position [a) and [b] (Fig. 7), corresponding to 
the deduced amino acid positions 75 and 81, respectively, in 
marmoset, a single nucleotide deletion resulted in a frameshift. 
At position 96 (position [cD, a single nucleotide substitution 
resulted in a premature stop codon. As described under "Aber-
rant Splicing Sites," a single nucleotide deletion was detected 
at position [d] ofthe exon 8 splicing junction. At position 268 [j), 
a single nucleotide substitution also resulted in a premature 
stop codon. 
In the orangutan, a single nucleotide deletion was observed 
at position [b] and Ig]. A premature stop codon was observed at 
position ffl. 
In human, a single nucleotide deletion was observed at the 
position [b), [e] and Ig). A premature stop codon was observed at 
position ffl and [hJ. 
Three critical mutations were observed within exon 7, lead-
ing to the predicted nonfunctional al,3GT expression in all 
frames (Figs. 6 and 7). At position [a] or [b] in the rhesus, 
corresponding to the deduced amino acid at positions 75 or 
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AREB6 
ZID PADS NMYC VDR 
R(-497): TTCCAGCTCC ATCACTGACA CCACCACCAC CACCCCGTGC AGGCCCAAGA AGGCAAAAGA GGCCCAGTCA CTCTCACCGG 
* ** ***** * **** ***** ***** *** **** ***** ******* ** '* ****** * 
P(-492): T--------- ---------c CCTCCACCCC CACCACGTGC AGGCCAGAGA AGGC-AAAGA GGCCCAGCCA CCCTCACCAG 
NFKB IRFl AREB6 AREB6 
R(-417): GGACTCTACT TTCTTTTTTT GCTGGTTTCA GGCTTTTTTC TGCCTGAGTG AAAATGAAAC AAACACACCC -GCGCC-CCC 
*** * * * ********** ********** ********** ********** ********** ****** *** ***** *** 
P(-431): GGAATTTCTT TTCTTTTTTT GCTGGTTTCA GGCTTTTTTC TGCCTGAGTG AAAATGAAAC AAACACCCCC TGCGCCTCCC 
WTl PAXS USF SPl 
R(-339): GGC------A CACACA---- CACACTCATT CATGCATTCA CG-CGGCGGC CTCCCAGCCG TCTGTGTCCA GGGCGGGGAC 
*** * ****** *** ** * '* *** ** ** * **** **** ** ** * ***** **** ***** 
P(-351): GGCCACCAGA CACACACGCG CACCGGCACT CGCGCACTCG CGCCCTCGGC CTCCTAG-CG GCCGTGTCTG GGGC-GGGAC 
NFl SPl 
R(-270): TGGCTTGGCA CCGACCGCTG CCGGCCGGGC ACAG------ -TGCGCCGCC CGCTG-TCAG'CGCTCGCCGG -TCCCTCGCG 
*** *** * ** ** * * ******* ** ******* *** '* *** ** ****** * ******* 
P(-273): CCGCTCTGCA CAAACAGCCG CGGGCCGGGT GGAGCGGGGA GCTCGCCGCC CGCCGCCCAG TGCCCGCCGG CTTCCTCGCG 
NRSF MTF-l AP2 
R(-199): CCCCTGCCCG CTGCGCTATG CCCAGAGCGG ACGCCCAGCC GGCCGGCCCA CGGGCAGGAG TACGGGC-GC ACGCTCTGGC 
********** * '* * *** *** * * '* *** '* ****** ***** **** * *** ** ** * * ** 
P(-193): CCCCTGCCCG C--CAC---- CCCGGAG-GA GCACACAG-C GGCCGG---- CGGGCCGGAG CGCAGGCGGC ACAC-CCCGC 
MUSCLE NRSF 
R(-120): GGAGGCAGCG AGGTAGCTGA TCCC---AGC GCGGCGGGCC CCGCGGTGGC CGGGAGCTAG G-CGCGGTC- -CTGCTCAGC 
**** ** * ** ** * * *** ** ** ** ** * ** * * * ** * *** * * * * * 
P(-126): CCCGGCA-CG CCCT-GCCGA GCTCAGGAGC ACGCCGCGCG CCACTGTTCC CTCAGCCGAG GACGCCGCCG GGGGGCCGGG 
-1 
R (-46): CCGCTCGCTG CGCGCCGGTC CTGGGTG--C CAGGGTTCTG CGGATCAGgtgggtcccgcagggcgccgccaggtcccc-ggag 
* * ** * *** * * * * * * * * ***** * ***************** ****** *** * **** **** 
P (-48): AGCCGAGGTG TGGGCCATCC CCGAGCGCAC CCAGCTTCTG CCGATCAGgtgggtcccgctgggcgctgcccgagcccctggag 
FIG. 4. Exon 1 vicinity of al,3GT gene of rhesus (R) compared with pig (P). The rhesus exon 1 and its potential regulatory region (capital 
letters) are aligned with the corresponding porcine exon 1 sequence (12). The lowercase letters denote intron 1. An asterisk indicates that the 
nucleotide is identical between both species. 
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FIG. 5. Luciferase assay for promoter activity of the rhesus al,3GT gene. 
81, respectively, in marmoset, a single nucleotide deletion, G, 
from the triplet GAA (mu) was identified, resulting in a 
frameshift. At position 96 (position [cD, a single nucleotide 
substitution resulted in a premature stop codon (from TGG 
(Trp) to TGA). At position 268 ([fl, a single nucleotide substi-
tution resulted in an additional premature stop codon (TAT 
(Tyr) to TAG). 
A single nucleotide deletion at position fg] was observed in 
both human and orangutan but not in rhesus. The premature 
stop codon at position [h] was observed only in human. Thus, 
five crucial mutations that might account for loss of a1,3GT 
expression were determined in human and rhesus and three 
in orangutan. It is noteworthy that the mutations at position 
[b] and [fl were shared by the rhesus monkey, ape, and 
human. 
DISCUSSION 
The aGal epitopes are chemically related to the ABO blood 
type antigens. In the absence of expression of A or B epitopes or 
of aGal epitopes, antibodies develop against the respective 
antigens. Phylogenetic data on the emergence of the ABO an-
tigen system (19) and especially molecular studies on ABO 
transferase (20) have been valuable in determining higher pri-
mate evolution. In contrast, little comparable information is 
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FIG, 6. Comparisons of deduced amino acid sequences of the al,3GT gene in marmoset (M), cebus (C), rhesus (R), orangutan (0), 
and human (m. Nucleotide sequences are shown from the start codon to the stop codon of the marmoset monkey cDNA in one-letter abbreviations, 
Dashed horizontal lines indicate that each nucleotide is identical to the corresponding nucleotide of the marmoset base-line sequence. The single 
asterisk in cebus denotes a triplet nucleotide deletion not present in the marmoset, A single nucleotide deletion, depicted by a slash (f), was observed 
at positions [a], [bl, [el, and [g], Premature termination, depicted by an X, was observed at positions tel, [fl, and [h]. 
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FIG. 7. Comparison of crucial point mutations of the al,3GT gene in primates. The numbered open boxes (top) are exons in which crucial 
mutations in the primates are shown with the corresponding nucleotide sequence. No mutations were observed in ",Gal-positive primates. Crucial 
mutations were observed in exons 7 and 9 of the three higher primate species examined (lower boxes). Note that the mutations at position lb] and 
[fl (lower closed boxes with thick lines) are shared by rhesus, orangutan, and human. (F / S), frameshift; (Stop), stop codon. 
known about the molecular basis of inactivation of the gene 
expressing the enzyme a1,3GT upon which synthesis of the 
aGal epitope depends. 
The aGal system in lower mammals was not discovered until 
the 1980s (1, 2). Evidence of the presence of a1,3GT gene 
homologues in some aGal-negative higher primates was pub-
10120 Primate cxl,3-Galactosyltransferase Gene 
lished in 1989-1991 by three pioneer groups. Joziasse et ai. (7) 
described an 89-bp sequence (HGT-I0) in human cells that was 
similar to a fragment of the murine and bovine exon 4. Larsen 
et al. (5) characterized a 703-bp genomic sequence in human 
tissue with a high degree of homology to exon 9 of the mouse 
al,3GT gene. Galili and Swanson (6) reported a 371-bp se-
quence in rhesus cells that resembled part of mouse and bovine 
exon 9. 
All three groups concluded that point mutations in exon 9 at 
some time in the evolutionary past of the higher primates could 
be the cause of the loss of aGal epitope expression. We con-
firmed the point mutations that had been described earlier in 
exon 9 of the rhesus (6), orangutan (6), and human al,3GT 
gene (5, 6), and demonstrated four additional point mutations 
in exons 7 and 8. The crucial mutations in the different species 
that result in frameshift and premature termination of trans-
lation include a deletion mutation at position [b] in exon 7 and 
a premature termination at position rtJ in exon 9 that are 
shared by all three of these higher primates. 
Because no al,3GT transcripts could be found in the early 
investigations of the African green monkey (COS) and human 
cell lines (4), the possibility could not be dismissed that inac-
tivation of the gene in the higher primates is due to mutations 
in the upstream regulatory regions of the a1,3GT gene (16). 
This potential explanation for loss of the aGal epitope was 
eliminated in our study using sensitive PCR methods for de-
tection ofmRNA transcripts that were not available at the time 
of the seminal investigations (4-7). A variety of transcripts 
with more than 10 different splicing patterns of the al,3GT 
gene were observed in the full coding region in all rhesus, 
orangutan, and human tissues examined. Their presence was 
confirmed with Northern blot of total RNA derived from rhesus 
spleen. 
Joziasse et al. (7, 16) estimated that inactivation of the 
a1,3GT gene occurred between 40 and 25 millions years ago, 
following the divergence between higher primates (ca-
tarrhines) and the New World monkey but prior to the further 
divergence of the individual higher primates. The hypothesis 
was based on their discovery of an intron-less processed eDNA 
homologue (termed HGT-21 in the human genome (7, 16). In 
contrast, Galili and Swanson (6) postulated that inactivation 
occurred at a much later time and independently in Old World 
monkeys, apes, and humans (6). Our finding of crucial point 
mutations shared by the rhesus, orangutan, and human at 
positions [b] and rtJ of exons 7 and 9, respectively, appears to be 
more consistent with Joziasse's hypothesis (16) that the 
al,3GT gene inactivation occurred in a common ancestor than 
with the suggestion by Galili and Swanson (6) that it occurred 
independently in the three different lineages. However, the 
time and the process of the inactivation remain to be deter-
mined (6, 7). The high homology of the a1,3GT gene in the 
aGal-negative species to the shared sequence of the aGal-
positive marmoset and cebus (Fig. 7) suggests that the inacti-
vation may have occurred more recently than previously 
thought. 
The development of preformed antibodies directed against a 
wide range of microorganisms or macroparasites that express 
aGal-like substance has been the conventional explanation for 
the evolution of the aGal-negative state in higher primates (1, 
2). The possibility cannot yet be excluded, however, that some 
other survival advantage drove the gene inactivation and that 
the protection from such infecting agents afforded by the "nat-
ural" anti-aGal antibodies was fortuitous. Whatever the rea-
son, antibodies against the aGal epitope are responsible for the 
immediate (hyperacute) rejection by aGal-negative recipients 
of tissues and organs from aGal-positive donors, precluding 
successful clinical xenotransplantation from aGal-positive an-
imals (3). Detailed information about the a1,3GT gene may 
help in mapping strategies for transgenic modification of the 
aGal-positive species. 
If higher primates were to spontaneously recover the expres-
sion of aGal epitopes, as has been described in normal breast 
and MCF7 human breast carcinoma cell lines (21), the poten-
tial for the development of aGal antibody-mediated autoim-
mune disease is implicit. Galili and co-workers (22) observed 
the presence of aGal epitopes in thyroid cells of a human with 
autoimmune Grave's disease, but no transcripts could be de-
tected in these cells with Northern blot. A search for al,3GT 
mRNA transcripts in tissues from such "autoimmune suspect" 
patients may be fruitful with more sensitive PCR technology 
used in our study. 
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